JPRN-UMIN000047903Recruiting未知
Translational research of "A multicenter Phase II basket study of Brigatinib in patients with ALK fusion gene-positive advanced/recurrent solid tumors" - WJOG15221MTR
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- West Japan Oncology Group
- Enrollment
- 14
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Others,meta-analysis etc
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Not Applicable
TiFFANY TRsolid malignanciesJPRN-jRCT1080224720ational Cancer Center Hospital East26
Not yet recruiting
Phase 4
A multicenter, prospective, real-world study on the treatment of stable chronic obstructive pulmonary disease with Guben Kechuan granuleschronic obstructive pulmonary diseaseITMCTR2024000226Shanghai University of Traditional Chinese Medicine Affiliated Shuguang Hospital
Completed
Not Applicable
TR accompanied with the study titled A multicenter phase II study of Nivolumab monotherapy in recurrent and/or metastatic gastrointestinal cancer patients with high Tumor Mutation Burden (TMB-H).Colorectal cancer, Gastric cancer, Esophageal cancer, Biliary tract cancer, Pancreatic cancer, and Other Solid cancerJPRN-UMIN000033560ational Cancer Center Hospital East70
Recruiting
Not Applicable
Development of a non-interventional, multicenter registry for immune-mediated neuropathies with a study-specific biobank (Immunemediated Neuropathies Biomaterial and Data Register - INHIBIT-Register)G61.8G61.0Other inflammatory polyneuropathiesGuillain-Barré syndromeDRKS00024494Ruhr-Universität Bochum St. Josef-Hospital Klinik für Neurologie1,000
Active, not recruiting
Not Applicable
A multicentre phase I-II study to investigate the combination of bendamustine with weekly paclitaxel as first or second line therapy in patients with metastatic breast cancer - RitaA multi-centre phase I-II study to investigate the combination of bendamustine with weekly paclitaxel as first or second line therapy in patients with metastatic breast cancerMedDRA version: 13.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2004-004880-31-DEGerman Breast Group Forschungs GmbH60